Ceribell, Inc. (CBLL) stock
CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30134% above fair value
$25.63−0.34 (-1.31%)
Close on Nov 18, 2026Market cap $983.63MP/E –Yield –
Ceribell net income
Net income is the profit left for shareholders after every expense, interest and tax.
Ceribell's net income for the twelve months ending Jun 30, 2026 was -$66.00M. For fiscal 2025 it was -$53.41M.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$53.41M | – |
| FY2024 | Dec 31, 2024 | -$40.46M | – |
| FY2023 | Dec 31, 2023 | -$29.46M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$19.27M | – |
| Q1 FY2026 | Mar 31, 2026 | -$19.74M | – |
| Q4 FY2025 | Dec 31, 2025 | -$13.53M | – |
| Q3 FY2025 | Sep 30, 2025 | -$13.47M | – |
| Q2 FY2025 | Jun 30, 2025 | -$13.64M | – |
| Q1 FY2025 | Mar 31, 2025 | -$12.78M | – |
| Q4 FY2024 | Dec 31, 2024 | -$12.58M | – |
| Q3 FY2024 | Sep 30, 2024 | -$10.42M | – |
| Q2 FY2024 | Jun 30, 2024 | -$8.94M | – |
| Q1 FY2024 | Mar 31, 2024 | -$8.52M | – |
| Q4 FY2023 | Dec 31, 2023 | -$8.27M | – |
| Q3 FY2023 | Sep 30, 2023 | -$7.05M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.22M | – |
| Q1 FY2023 | Mar 31, 2023 | -$7.92M | – |
See a number that looks wrong?